Search

everythinglearnresearchcommunity

for

Search:↓

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

Deucravacitinib helped a man regrow hair significantly.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Experts recommend specific treatments for alopecia areata based on age and severity, emphasizing the need for better treatments and acknowledging its psychological impact.

Iron chelators can effectively reduce hair loss and improve hair growth in autoimmune alopecia.

A 22-year-old man has alopecia areata, an autoimmune hair loss condition, with various treatments available.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Combination therapy effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

New and repurposed treatments are improving outcomes in dermatology.

The guideline provides recommendations for managing alopecia areata effectively.

Improving education, insurance, and support can help scarring alopecia patients access better care.

Baricitinib is an effective treatment for severe alopecia areata.

Blocking JAK-STAT signaling can lead to hair growth.

Three compounds from Dadap leaves may help treat hair loss.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Baricitinib may effectively treat oral lichen planus.